Ledger.Open graph →
SEC Form D · Amendment · filed July 2, 2013

GENOCEA BIOSCIENCES, INC

Offering
$30.5M
Sold
$30.5M
Exemption
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

People & firms on this filing (24)

Melvin L. Kupperman · New York, NYDirectorTal S. Kerret · New York, NYExec · DirectorLisa L. Silverstein · New York, NYExecSeth Hetherington · CAMBRIDGE, MAExecRavi Venkataramani · CAMBRIDGE, MAExecSimeon George · CAMBRIDGE, MADirectorStephen Hoffman · CAMBRIDGE, MADirectorKevin Bitterman · CAMBRIDGE, MADirectorRobert E. Farrell Jr · CAMBRIDGE, MAExecAsish Xavier · CAMBRIDGE, MADirectorPaul Giannasca · CAMBRIDGE, MAExecRobert Paull · CAMBRIDGE, MADirectorTimothy N. Yuckman · Birmingham, ALExecTom Bacon · HOUSTON, TXDirectorJordan Jones · Birmingham, ALExec · DirectorLisa D. Earnhardt · Menlo Park, CADirectorRichard E. Kaufman · Menlo Park, CADirectorMonika A. De Martini · Menlo Park, CADirectorRick Anderson · Austin, TXDirectorFrederic H. Moll · Menlo Park, CAExecCasper De Clercq · Palo Alto, CAExecVictor Kats · St. Louis, MOExecRachel J. Cherney · Santa Ana, CAExecRobb Fujioka · El Segundo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗